Fischer Medical Ventures

816.00
-26.35
(-3.13%)
ann
There are new updates from the company1 day ago
Viewcross
right
Market Cap
5,206.18 Cr
EPS
1.65
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
907.00
52 Week Low
454.35
PB Ratio
15.70
Debt to Equity
0.03
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
855.95 21,805.86 49.01 15,707.00 -7.64 449 -110.82 54.38
1,138.35 14,370.28 16.31 8,798.90 -22.71 457 318.35 56.01
458.10 7,243.00 - 4,003.40 -20.27 -158 45.41 56.64
492.00 7,229.48 14.20 8,398.90 -20.68 485 68.04 42.72
614.30 5,882.22 9.96 3,498.80 -23.68 794 68.74 44.85
816.00 5,206.18 - 21.50 10,650.00 2 62.50 56.52
583.05 4,282.22 - 3,896.70 -14.52 -237 90.27 54.54
87.09 3,012.14 24.91 1,099.90 9.90 146 0.70 41.07
2,964.65 2,957.20 38.90 385.20 0.60 53 244.55 40.73
237.68 2,433.56 - 2,102.50 -2.77 -39 -82.61 48.80
Growth Rate
Revenue Growth
10,650.00 %
Net Income Growth
5,135.34 %
Cash Flow Change
-165.49 %
ROE
-83.45 %
ROCE
-46.88 %
EBITDA Margin (Avg.)
29.78 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
0
0
0
21
11
40
12
Expenses
0
0
1
18
10
39
11
EBITDA
0
0
-1
3
1
1
1
Operating Profit %
0 %
0 %
-347 %
12 %
-3 %
1 %
3 %
Depreciation
0
0
0
0
0
0
1
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
-1
3
0
0
0
Tax
0
0
0
0
0
-0
0
Net Profit
0
0
-1
3
-0
0
-0
EPS in ₹
0.00
0.00
0.00
0.48
-0.02
0.05
-0.05

Balance Sheet

Balance Sheet
2023
2024
Total Assets
0
86
Fixed Assets
0
15
Current Assets
0
70
Capital Work in Progress
0
0
Investments
0
1
Other Assets
0
70
Total Liabilities
0
86
Current Liabilities
0
4
Non Current Liabilities
1
1
Total Equity
-0
81
Reserve & Surplus
-0
27
Share Capital
0
54

Cash Flow

Cash Flow
2024
Net Cash Flow
1
Investing Activities
-29
Operating Activities
-8
Financing Activities
37

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Jan 2024
Mar 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Feb 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
74.91 %
74.91 %
74.91 %
74.91 %
62.81 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.07 %
5.07 %
5.07 %
5.07 %
5.07 %
5.06 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.68 %
1.68 %
1.68 %
1.68 %
1.68 %
1.41 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
96.72 %
96.72 %
96.61 %
94.42 %
94.38 %
94.43 %
94.43 %
94.23 %
94.20 %
99.60 %
97.60 %
97.59 %
29.75 %
29.37 %
16.47 %
16.48 %
16.39 %
16.37 %
25.30 %
Others
3.28 %
3.28 %
3.39 %
5.58 %
5.62 %
5.57 %
5.57 %
5.77 %
5.80 %
0.40 %
2.40 %
2.41 %
70.25 %
63.88 %
1.87 %
1.86 %
1.94 %
1.96 %
5.41 %
No of Share Holders
9,046
9,043
9,085
9,109
9,093
9,121
9,121
9,064
9,060
9,085
9,104
9,038
9,065
8,976
8,975
9,285
9,502
9,688
9,865

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Update By Material Subsidiary
8 hours ago
Board Meeting Intimation for Change In Independent Director And Other Related And General Corporate Purpose
1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
Mar 07, 2025
Announcement under Regulation 30 (LODR)-Allotment
Mar 04, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Mar 04, 2025
Integrated Filing (Financial)
Mar 03, 2025
Announcement under Regulation 30 (LODR)-Allotment
Mar 03, 2025
Integrated Filing (Financial)
Mar 03, 2025
Announcement Relating To Proposed Investment Of Funds In Wholly Owned Subsidiary
Feb 26, 2025
Announcement Relating To Proposed Investment Of Funds In Wholly Owned Subsidiary
Feb 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 21, 2025
Update On Receipt Of Disclosure Under Regulation 29(2) Of SEBI (SAST) 2015
Feb 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 18, 2025
Board Meeting Outcome for Allotment Of Equity Shares And Warrants
Feb 18, 2025
Announcement Under Regulation 30 - Incorporation Of Subsidiary Company
Feb 15, 2025
Board Meeting Outcome for RESULTS - FINANCIAL RESULTS - 31.12.2024
Feb 14, 2025
Results - Financial Results For 31/12/2024
Feb 14, 2025
Update From Material Subsidiary
Feb 13, 2025
Announcement Under Regulation 30 - Update On Re- Constitution Of Audit Committee
Feb 12, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31.12.2024
Feb 07, 2025
Intimation Of Supply Of 10 Nos. Of 1.5T Whole Body MRI Machines To Atrium Diagnostics
Feb 05, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Feb 02, 2025
Announcement under Regulation 30 (LODR)-Meeting Updates
Feb 02, 2025
Announcement under Regulation 30 (LODR)-Meeting Updates
Jan 31, 2025
Proceedings Of Extra Ordinary General Meeting Dated 31.01.2025
Jan 31, 2025
Intimation Of Development Of Advanced AI Powered Healthcare Solutions By Wholly Owned Subsidiary Of The Company
Jan 27, 2025
Intimation Of Launch Of Sikkim MRI Public - Private Partnership (PPP) Project
Jan 20, 2025
Intimation Of License To Manufacture MRI By CDSCO To The Material Subsidiary Of The Company
Jan 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 10, 2025
Shareholders Meeting - EGM On 31/01/2025
Jan 09, 2025
Announcement under Regulation 30 (LODR)-Meeting Updates
Jan 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Is Enclosed Herewith
Jan 03, 2025
Closure of Trading Window
Dec 31, 2024
Announcement under Regulation 30 (LODR)-Investor Presentation
Dec 28, 2024
Announcement Under Regulation 30- Update On Upcoming Board Meeting
Dec 28, 2024
Board Meeting Intimation for To Consider Approve Business Items Relating To Preferential Issue And Other Business Item
Dec 28, 2024
General Update
Dec 16, 2024
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Nov 30, 2024
Update Of Incorporation Of Subsidiary Company
Nov 14, 2024
RESULTS 30/09/2024
Nov 14, 2024
Board Meeting Outcome for OUTCOME OF BOARD MEETING
Nov 14, 2024
Board Meeting Scheduled On 13/11/2024 To Consider And Approve Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2024
Nov 05, 2024
Update on board meeting
Nov 05, 2024
Board Meeting Intimation for Unaudited Standalone And Consolidated Results For The Quarter And Half Year Ended 30.09.2024
Nov 05, 2024
Update On Foreign Subsidiary
Oct 18, 2024
Board Meeting Outcome for Revised Outcome
Oct 15, 2024

Technical Indicators

RSI(14)
Neutral
64.66
ATR(14)
Volatile
53.87
STOCH(9,6)
Neutral
63.17
STOCH RSI(14)
Overbought
86.45
MACD(12,26)
Bullish
1.43
ADX(14)
Weak Trend
24.10
UO(9)
Bearish
50.53
ROC(12)
Uptrend And Accelerating
8.44
WillR(14)
Neutral
-35.37